Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **cone photoreceptor cell** is a specialized neuron found in the retina of the vertebrate eye, responsible for initiating vision by absorbing light and converting it into electrical signals in a process called phototransduction[1][4][6]. Cones are active under bright (daylight) conditions and are essential for color vision and high visual acuity[2][7]. There are three subtypes of cone cells in humans: S-cones (short wavelength, blue), M-cones (medium wavelength, green), and L-cones (long wavelength, red), each containing different photopsins (cone opsins), which define their spectral sensitivity[4][5][6][7]. Cone cells are structurally characterized by outer and inner segments, a nucleus, and a synaptic terminal. Their outer segments contain invaginations with stacks of membranous disks where photopigments reside; these disks are continuous with the plasma membrane, distinguishing cones from rod photoreceptors[2][4]. The highest density of cones is found in the fovea, the central part of the retina responsible for sharp central vision, whereas their number decreases in the peripheral retina[5][7]. Cone degeneration or dysfunction causes diseases such as color blindness, cone dystrophies, and contributes significantly to vision loss in conditions like age-related macular degeneration and retinitis pigmentosa[1][6]. **Note:** - "Retinal cone photoreceptors" (plural) refers to a cell type—a population, not a single protein, enzyme, or druggable therapeutic target. While essential to vision, individual cone photoreceptor cells are not usually referred to as "therapeutic targets" in the standard sense used for receptors, enzymes, or transporters in drug development. Instead, molecular components within cone cells (e.g., cone opsins, cGMP-gated channels, etc.) are the typical drug targets. - No drugs are currently known to directly target cone photoreceptor cells as a class; interventions focus on protecting photoreceptors, slowing degeneration, or gene/protein replacement for disease-causing mutations within cones.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cone photoreceptor cell.